Large language models (LLMs) show considerable promise for clinical decision support (CDS) but none is currently authorized by the Food and Drug Administration (FDA) as a CDS device. We evaluated whether two popular LLMs…
Continue Reading
Tag: AI Group
Healthcare-associated infections (HAIs) from multi-drug resistant organisms (MDROs) pose a significant challenge for healthcare systems. Patients can arrive at hospitals already infected (“importation”) or acquire infections during their stay (“nosocomial infection”). Many cases, often…
Continue Reading
HIMSSCast: Fundamentals of data governance – lessons from UNC Health, part 3
In this third episode of a three-week series of HIMSSCast, we again speak with UNC Health’s System Director for Analytical Solutions Greg Kuhnen. This time, he is joined by his colleague Ram Rimal, UNC’s…
Continue Reading
6 HIMSS Announcements You Don’t Want to Miss
This year’s HIMSS conference in Las Vegas, which wrapped on Thursday, allowed healthcare technology leaders from around the world to convene and share ideas. As always, the event came with a slew of news…
Continue Reading
ModMed Launches AI-Powered Scribe for Dermatology to Transform Clinical Documentation
What You Should Know:
– ModMed, a provider of specialty-specific healthcare technology announced the upcoming launch of ModMed Scribe, an AI-powered ambient listening solution designed to revolutionize EHR documentation for dermatologists.
– The tool automates note-taking,…
Continue Reading
Applying AI in the Context of the Association Between Device-Based Assessment of Physical Activity and Mental Health: Systematic Review
Background: Wearable technology is used by consumers worldwide for continuous activity monitoring in daily life but more recently also for classifying or predicting mental health parameters like stress or depression levels. Previous studies identified,…
Continue Reading
Systematic review and meta-analysis of artificial intelligence in classifying HER2 status in breast cancer immunohistochemistry
The DESTINY-Breast04 trial has recently demonstrated survival benefits of trastuzumab-deruxtecan (T-DXd) in metastatic breast cancer patients with low Human Epidermal Growth Factor Receptor 2 (HER2) expression. Accurate differentiation of HER2 scores has now become…
Continue Reading
MSK to Deploy Abridge’s AI Oncology Clinical Documentation
What You Should Know:
– Abridge announced that its AI platform to support clinical conversations will be utilized by Memorial Sloan Kettering Cancer Center (MSK) clinicians in an extensive rollout that will take place throughout 2025…
Continue Reading
NHS AI adoption in London remains fragmented, finds report
A report by UCLPartners and the Health Foundation has found that while AI has the potential to improve patient care and operational efficiency, its adoption remains fragmented in London.
The report, ‘AI in London healthcare:…
Latitude Health Launches AI-Native Utilization Management Solution
What You Should Know:
– Latitude Health, a San Francisco, CA-based company is emerging out of stealth with the launch of its AI-driven utilization management designed to eliminate inefficiencies, reduce costs, and improve patient outcomes.
–…
Continue Reading